Characterization of different soluble TNF receptor (TNFR80) derivatives: Positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacity

Journal of Interferon and Cytokine Research

Volumn 16, Issue 6, 1996, Pages 471-477

  Moosmayer, Dieter ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOLUBILIZATION; VIRUS NEUTRALIZATION;

INSECTA;

EID: 0030013085     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.471     Document Type: Article

References (4)

1. BEUTLER, B., MILSARK, I.W., and CERAMI, A.C. (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871.
2. PIGUET, P.F., GRAU, G.E., ALLET, B., and VASSALLI, P. (1987). Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166, 1280-1289.
3. OLIFF, A., DEFEO-JONES, D., BOYER, M., MARTINEZ, D., KIEFER, D., VUOCOLO, G., WOLFE, A., and SOCHER, S.H. (1987). Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50, 555-563.
4. KEFFER, J., PROBERT, L., CAZLARIS, H., GEORGOPOULOS, S., KASLARIS, E., KIOUSSIS, D., and KOLLIAS, G. (1991). Transgenic mice expressing human tumour necrosis factor: A predictive genetic model for arthritis. EMBO J. 10, 4025-4031.